Clinical-Microbiomics A/S: Financial statements 2023
CVR: 37230634
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Clinical-Microbiomics A/S (CVR 37230634) has filed annual accounts for 2023. In 2023, the company reported a gross profit of EUR 1,779,000 and a net result of EUR -1,951,000 compared with DKK -6,908,831 the year before. That is a decrease of 90.6% compared with the year before. Equity in the 2023 report amounted to EUR 86,290,000. The solvency ratio was 95.6%. The company had 82 employees in the financial year.
- Gross Profit
- EUR 1,779,000
- Profit/Loss
- EUR -1,951,000
- Equity
- EUR 86,290,000
- Total Assets
- EUR 90,236,000
- Employees
- 82
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.8M EUR | -2M EUR | 86.3M EUR | 82 |
| 2022 | - | 19M | -6.9M | 119.5M | 32 |
| 2021 | - | 16.8M | -1.7M | 2.8M | 26 |
| 2020 | - | 17M | 816K | -3.3M | 19 |
| 2019 | - | 13.2M | 107K | -4.1M | 16 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 9, 2023, Morten Otto Alexander Sommer has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Manoj Nirmal Dadlani has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Nathan Allen Ledeboer has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Bruce Harvey Grant has joined the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Rasmus Vendler Toft-Kehler has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Torben Thomasen has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Henrik Dalbøge has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, Thomas Alsbjerg has left the board of directors of Clinical-Microbiomics A/S.
As of October 9, 2023, MANJIN ApS is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
As of October 9, 2023, VENDLER ApS is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
About Clinical-Microbiomics A/S
Clinical-Microbiomics A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Clinical-Microbiomics ApS. The management consists of Anders Christian Neto de Sousa Grøn. The board consists of Manoj Nirmal Dadlani (chair), Bruce Harvey Grant, Caroline Popper and Isabelle Valerie de Cremoux. The company's owners include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF. The company has 32 employees (2026). In 2025, the company reported a gross profit of EUR 2,831,000 and a net result of EUR -2,586,000 compared with EUR -4,328,000 the year before. Equity in the 2025 report amounted to EUR 85,447,000.